NIH Grand Rounds Interactive TV Series Will Premiere Next Year

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 5 No 10
Volume 5
Issue 10

BETHESDA, Md--A clinical education television series--Bench to Bedside--NIH Grand Rounds--is set to debut on January 15, 1997. Once a month, the world's leading clinicians from the various NIH institutes will discuss critical medical topics of the day.

BETHESDA, Md--A clinical education television series--Bench toBedside--NIH Grand Rounds--is set to debut on January 15, 1997.Once a month, the world's leading clinicians from the variousNIH institutes will discuss critical medical topics of the day.

The interactive program, sponsored by the NIH and CenterNet, thetelevision network of the Association of Academic Health Centers,will offer category 1 CME credit and will be made available toinstitutions outside of academic centers, including VA and communityhospitals.

For CenterNet subscription information, write: CenterNet, c/oHMTV, 1800 Diagonal Road, Suite 600, Alexandria, VA 22314 or callTom Shaw at 703-684-4415. The network can provide technical assistancefor institutions wishing to receive CenterNet programming.

Recent Videos
According to Jorge Nieva, MD, there are a multitude of things that can be explored to enhance the treatment landscape for lung cancer.
5 experts are featured in this series
2 experts are featured in this series.
5 experts are featured in this series
2 experts are featured in this series.
Taletrectinib showed improved efficacy in patients with ROS1-positive non–small cell lung cancer who were treatment-naïve.
“It’s a drug that I’m very comfortable with, and it is a drug I’ll likely use primarily in the first-line setting,” stated Jorge Nieva, MD, on taletrectinib in non–small cell lung cancer.
4 experts in this video
4 experts in this video
Those being treated for peritoneal carcinomatosis may not have to experience the complication rates or prolonged recovery associated with surgical options.
Related Content